Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a with or without adefovir in inactive HBsAg carriers
ChiCTR-OPN-15007410Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a and adefovir dipivoxil in Chronic Hepatitis B (CHB) and hepatitis B (HBV) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: HBsAg clearance rate at week 96. Started Jan 2016; status: recruiting.
02
Drugs
peginterferon alfa-2aadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR-OPN-15007410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15007410.